← Leaderboards
Robert E Lanford
Southwest Foundation For Biomedical Res
$16,891,565
Attributed
$16,891,565
Total exposure
93
Grants
71
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.1M · FY2005–19$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$32,914,806 · 95
By mechanism
U42$16,079,816 · 3
R01$6,991,838 · 4
U19$4,303,072 · 3
P51$3,921,912 · 81
R21$783,519 · 2
G20$498,810 · 1
Top collaborators
- John Charles Bernal4 shared
- Geoffrey David Clarke1 shared
- Laura A Cox1 shared
- Ralph A Defronzo1 shared
- Peter Thornton Fox1 shared
- Deepak Kaushal1 shared
- Cun Li1 shared
- Peter W Nathanielsz1 shared
Most similar at Southwest Foundation For Biomedical Res
Same institution · by research overlap
- Burton Beames$222,224
- Linda Y Brent$14,525,767
- Cornelius Rinjbrand$70,429
Others in their field
Top investigators on “Hepatitis C Virus”
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Sharon A Nachman · Johns Hopkins University$91,575,784
- Peter B. Gilbert · Fred Hutchinson Cancer Center$77,122,577
- Robert Turner Schooley · University Of Colorado Denver$45,719,253
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$44,694,148
- Charles M. Rice · Rockefeller University$42,549,577
Research focus
Hepatitis C VirusUnited States National Institutes Of HealthPrimatesGrantFundingResourcesResearch PersonnelSourcePan GenusAnimalsViralMalignant Neoplasm Of LiverCirrhosisAntiviral AgentsInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseInfectionHepatitis CLiver DiseasesVirusMonitorLiverImmune ResponseChronic
Grant awards (131)
Establishment of a SPF Rhesus Macaque Colony$2,324,981
U42 · FY2019 · OD · contact PI
Husbandry and Management Core$2,085,269
U42 · FY2019 · OD · contact PI
Womb to Tomb: Developmental Programming and Aging Interactions in Primates$2,678,696
U19 · FY2018 · AG
Establishment of a SPF Rhesus Macaque Colony$2,414,556
U42 · FY2018 · OD · contact PI
Establishment of a SPF Rhesus Macaque Colony$2,239,132
U42 · FY2017 · OD · contact PI
Establishment of a SPF Rhesus Macaque Colony$2,059,970
U42 · FY2016 · OD · contact PI
Establishment of a SPF Rhesus Macaque Colony$1,856,331
U42 · FY2015 · OD · contact PI
Renovation of Facilities for Macaque Housing at the SNPRC$498,810
G20 · FY2015 · OD · contact PI
NIH-Owned Chimpanzee Research Resource at the SNPRC$1
U42 · FY2015 · OD · contact PI
Establishment of a SPF Rhesus Macaque Colony$1,667,796
U42 · FY2014 · OD · contact PI
Establishment of a SPF Rhesus Macaque Colony$781,779
U42 · FY2014 · OD · contact PI
The Innate Immune Response in the Marmoset Model of GBV-B Infections: A Surrogate$552,679
R01 · FY2014 · AI · contact PI
NIH-Owned Chimpanzee Research Resource at the SNPRC$1
U42 · FY2014 · OD · contact PI
NIH-Owned Chimpanzee Research Resource at the SNPRC$650,000
U42 · FY2013 · OD · contact PI
The Innate Immune Response in the Marmoset Model of GBV-B Infections: A Surrogate$519,519
R01 · FY2013 · AI · contact PI
The Innate Immune Response in the Marmoset Model of GBV-B Infections: A Surrogate$552,679
R01 · FY2012 · AI · contact PI
The Innate Immune Response in the Marmoset Model of GBV-B Infections: A Surrogate$547,534
R01 · FY2011 · AI · contact PI
SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP$80,544
P51 · FY2011 · RR · contact PI
CONVERSION OF IFN? NULL RESPONDER PHENOTYPE IN TO IFN RESPONDER PHENOTYPE$72,347
P51 · FY2011 · RR · contact PI
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$57,080
P51 · FY2011 · RR · contact PI
EFFICACY OF TLR7 AGONIST FOR CHRONIC HCV INFECTION IN CHIMPANZEES$50,613
P51 · FY2011 · RR · contact PI
EFFICACY OF TLR7 AGONIST FOR CHRONIC HBV INFECTION IN CHIMPANZEES$40,986
P51 · FY2011 · RR · contact PI
EVALUATION OF ANTIBODY IMMUNOTHERAPY FOR HCV IN CHIMPANZEES$36,625
P51 · FY2011 · RR · contact PI
DEVELOPMENT OF A BABOON MODEL OF LIVER CANCER$35,572
P51 · FY2011 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$33,240
P51 · FY2011 · RR · contact PI
MOLECULAR SWITCH VACCINES FOR BIODEFENSE, CANCER, AND INFECTIOUS DISEASE$30,914
P51 · FY2011 · RR · contact PI
ANALYSIS OF CHIMPANZEE PK FOR GILEAD TLR AGONIST$24,141
P51 · FY2011 · RR · contact PI
EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES$489,289
P51 · FY2010 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$181,218
P51 · FY2010 · RR · contact PI
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$165,229
P51 · FY2010 · RR · contact PI
TLR LIGANDS IN GBV-B$106,599
P51 · FY2010 · RR · contact PI
HBV RESOLUTION IN CHIMPANZEES$102,335
P51 · FY2010 · RR · contact PI
IMPACT OF HUMAN MAB AGAINST HCV E2 SURFACE GLYCOPROTIEN ON HCV INFECTION$41,574
P51 · FY2010 · RR · contact PI
HCV CENTER STUDIES ON INFECTIOUS HCV$39,442
P51 · FY2010 · RR · contact PI
ANALYSIS OF CHIMPANZEE PK FOR GILEAD TLR AGONIST$30,914
P51 · FY2010 · RR · contact PI
PROTEIN BIOMARKERS FOR EARLY DETECTION OF LIVER CANCER$24,519
P51 · FY2010 · RR · contact PI
Virus-Host Interactions in Hepatitis C Virus (HCV) Infections$339,765
U19 · FY2009 · AI · contact PI
EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES$309,523
P51 · FY2009 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$186,356
P51 · FY2009 · RR · contact PI
NUCLEIC ACID BASED IMMUNOTHERAPEUTIC IN CHIMPANZEES INFECTED WITH HCV$104,275
P51 · FY2009 · RR · contact PI
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$87,217
P51 · FY2009 · RR · contact PI
TLR LIGANDS IN GBV-B$74,285
P51 · FY2009 · RR · contact PI
IMPACT OF HUMAN MAB AGAINST HCV E2 SURFACE GLYCOPROTIEN ON HCV INFECTION$70,525
P51 · FY2009 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$69,974
P51 · FY2009 · RR · contact PI
HBV RESOLUTION IN CHIMPANZEES$62,363
P51 · FY2009 · RR · contact PI
SAFETY OF A BACTERIAL IMMUNOTHERAPEUTIC IN CHIMPANZEES INFECTED WITH HCV$53,009
P51 · FY2009 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$49,707
P51 · FY2009 · RR · contact PI
INHIBITIONS OF CELLULAR FUNCTIONS AS ANTIVIRIAL THERAPY FOR HCV IN CHIMPANZEES$43,563
P51 · FY2009 · RR · contact PI
HCV CENTER STUDIES ON INFECTIOUS HCV$27,421
P51 · FY2009 · RR · contact PI
PROTEIN BIOMARKERS FOR EARLY DETECTION OF LIVER CANCER$16,691
P51 · FY2009 · RR · contact PI
WRCE Nonhuman Primate Core$335,839
U54 · FY2008 · AI · contact PI
Virus-Host Interactions in Hepatitis C Virus (HCV) Infections$329,820
U19 · FY2008 · AI · contact PI
GBV-B: A Small Primate Model for Hepatitis C Infection$311,605
R01 · FY2008 · AI · contact PI
Resolution of Acute Hepatitis B Virus Infections in Chimpanzees$222,579
R21 · FY2008 · AI · contact PI
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$22,141
P51 · FY2008 · RR · contact PI
HBV RESOLUTION IN CHIMPANZEES$9,136
P51 · FY2008 · RR · contact PI
HCV CENTER STUDIES ON INFECTIOUS HCV$3,933
P51 · FY2008 · RR · contact PI
EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES$3,870
P51 · FY2008 · RR · contact PI
CREATION OF IMMORTALIZED CHIMP AND BABOON HEPATOCYTE CELL LINES$1,967
P51 · FY2008 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$1,015
P51 · FY2008 · RR · contact PI
TLR LIGANDS IN GBV-B$952
P51 · FY2008 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$698
P51 · FY2008 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$381
P51 · FY2008 · RR · contact PI
Virus-Host Interactions in Hepatitis C Virus (HCV) Infections$323,128
U19 · FY2007 · AI · contact PI
GBV-B: A Small Primate Model for Hepatitis C Infection$317,640
R01 · FY2007 · AI · contact PI
Resolution of Acute Hepatitis B Virus Infections in Chimpanzees$225,940
R21 · FY2007 · AI · contact PI
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$166,398
P51 · FY2007 · RR · contact PI
GENE EXPRESSION ANALYSES DURING INTERFERON - ANTIVIRAL THERAPY$43,771
P51 · FY2007 · RR · contact PI
HCV CENTER STUDIES ON INFECTIOUS HCV$32,586
P51 · FY2007 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$14,103
P51 · FY2007 · RR · contact PI
EFFICACY OF SIRNA MOLECULES FOR GBV-B/HCV ANTIVIRAL THERAPY$7,989
P51 · FY2007 · RR · contact PI
EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES$5,488
P51 · FY2007 · RR · contact PI
EVALUATION OF AAV-SIRNA GENE THERAPY IN THE MARMOSET MODEL FOR GBV-B$3,265
P51 · FY2007 · RR · contact PI
SIRNA HCV ANTIVIRAL TESTING IN CHIMPANZEES$3,126
P51 · FY2007 · RR · contact PI
GBV-B: A Small Primate Model for Hepatitis C Infection$327,128
R01 · FY2006 · AI · contact PI
Virus-Host Interactions in HCV Infections$317,265
U19 · FY2006 · AI · contact PI
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$66,732
P51 · FY2006 · RR · contact PI
WMHBV: A SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$66,732
P51 · FY2006 · RR · contact PI
NONHUMAN PRIMATE RESPONSE TO INTERFERON ALPHA$29,367
P51 · FY2006 · RR · contact PI
GENE EXPRESSION ANALYSES DURING INTERFERON - ANTIVIRAL THERAPY$22,747
P51 · FY2006 · RR · contact PI
EFFICACY OF SIRNA MOLECULES FOR GBV-B/HCV ANTIVIRAL THERAPY$11,603
P51 · FY2006 · RR · contact PI
SIRNA HCV ANTIVIRAL TESTING IN CHIMPANZEES$11,603
P51 · FY2006 · RR · contact PI
EVALUATION OF AAV-SIRNA GENE THERAPY IN THE MARMOSET MODEL FOR GBV-B$11,603
P51 · FY2006 · RR · contact PI
EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES$7,735
P51 · FY2006 · RR · contact PI
HCV ANTIVIRAL TESTING IN CHIMPANZEES$7,735
P51 · FY2006 · RR · contact PI
IMMUNOMODULATIONOF HCV CHRONIC INFECTION IN CHIMPANZEES$1,967
P51 · FY2006 · RR · contact PI
ANTIVIRAL TESTING OF COMPOUNDS IN HBV INFECTED CHIMPANZEES$1,901
P51 · FY2006 · RR · contact PI
ANTIVIRAL EFFICACY OF HCV INHIBITOR IN INFECTED CHIMPANZEES$1,311
P51 · FY2006 · RR · contact PI
PHARMACOKINETICS OF NEW CEPHALOSPORINS$393
P51 · FY2006 · RR · contact PI
PHARMACOKINETICS OF ORAL IMMUNOMODULATOR IN CHIMPANZEES$328
P51 · FY2006 · RR · contact PI
GBV-B: A Small Primate Model for Hepatitis C Infection$335,000
R01 · FY2005 · AI
Virus-Host Interactions in HCV Infections$314,398
U19 · FY2005 · AI
Gene Expression Analyses During IFN Antiviral Therapy$167,500
R21 · FY2005 · DK
WMHBV: A SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$53,815
P51 · FY2005 · RR
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$53,815
P51 · FY2005 · RR
NONHUMAN PRIMATE RESPONSE TO INTERFERON ALPHA$23,687
P51 · FY2005 · RR
GENE EXPRESSION ANALYSES DURING INTERFERON - ANTIVIRAL THERAPY$18,337
P51 · FY2005 · RR
HCV ANTIVIRAL TESTING IN CHIMPANZEES$6,233
P51 · FY2005 · RR
EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES$6,233
P51 · FY2005 · RR
IMMUNOMODULATIONOF HCV CHRONIC INFECTION IN CHIMPANZEES$1,558
P51 · FY2005 · RR
ANTIVIRAL TESTING OF COMPOUNDS IN HBV INFECTED CHIMPANZEES$1,506
P51 · FY2005 · RR
ANTIVIRAL EFFICACY OF HCV INHIBITOR IN INFECTED CHIMPANZEES$1,091
P51 · FY2005 · RR
PHARMACOKINETICS OF NEW CEPHALOSPORINS$312
P51 · FY2005 · RR
PHARMACOKINETICS OF ORAL IMMUNOMODULATOR IN CHIMPANZEES$260
P51 · FY2005 · RR
WMHBV--SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$456,474
R01 · FY2004 · AI
GBV-B: A Small Primate Model for Hepatitis C Infection$335,000
R01 · FY2004 · AI
Gene Expression Analyses During IFN Antiviral Therapy$167,500
R21 · FY2004 · DK
WMHBV: A SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$110,551
P51 · FY2004 · RR
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$110,551
P51 · FY2004 · RR
NONHUMAN PRIMATE RESPONSE TO INTERFERON ALPHA$13,262
P51 · FY2004 · RR
EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES$5,516
P51 · FY2004 · RR
HCV ANTIVIRAL TESTING IN CHIMPANZEES$5,516
P51 · FY2004 · RR
ANTIVIRAL EFFICACY OF INHIBITORS OF HCV REPLICATION IN CHRONICALLY$5,516
P51 · FY2004 · RR
EVALUATION OF IMMUNE MODULATORS IN CHIMPANZEES$5,516
P51 · FY2004 · RR
WMHBV--SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$394,641
R01 · FY2003 · AI
GBV-B: A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$63,813
P51 · FY2003 · RR
WMHBV: A SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$63,813
P51 · FY2003 · RR
WMHBV--SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$39,834
R01 · FY2003 · AI
EVALUATION OF IMMUNE MODULATORS IN CHIMPANZEES$3,193
P51 · FY2003 · RR
EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES$3,193
P51 · FY2003 · RR
WMHBV--SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$383,147
R01 · FY2002 · AI
GBV-B-- A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$301,956
R01 · FY2002 · AI
VIRUS-HOST INTERACTION IN HCV INFECTION$0
U19 · FY2002 · AI
WMHBV--SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$371,986
R01 · FY2001 · AI
GBV-B-- A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$301,956
R01 · FY2001 · AI
VIRUS-HOST INTERACTION IN HCV INFECTION$0
U19 · FY2001 · AI
WMHBV--SMALL PRIMATE MODEL FOR HEPATITIS B VIRUS$361,151
R01 · FY2000 · AI
MODEL SYSTEMS FOR ANALYSIS OF HBV REPLICATION$335,909
R01 · FY2000 · CA
GBV-B-- A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTION$246,000
R01 · FY2000 · AI
MODEL SYSTEMS FOR ANALYSIS OF HBV REPLICATION$3,959
P51 · FY2000 · RR
VIRUS-HOST INTERACTION IN HCV INFECTION$0
U19 · FY2000 · AI